Abstract
Asthma is an allergic disease that affects approximately 300 million people worldwide. Two of its phenotypes routinely assessed at the clinic include airway hyperresponsiveness and IgE production. They can be measured in a non-invasive manner and have been used for genetic studies.
The genetic complexity of asthma and its phenotypes makes it difficult to map their genetic contributors. Human studies require large sample sizes and proper segregation of the population to control for potential confounding factors. As an alternative, asthma genetics can be studied in mice due to the high degree of homology in the genome and immune response between mice and humans. The variety of mouse strains and allergic asthma protocols allow to study different aspects of the disease while controlling for the genetic background. Studying the genetic basis of asthma phenotypes has helped gain a better understanding of the disease mechanism. Candidate genes identified from genetic studies have served as targets for the development of new and specialized treatments. New treatments are high in demand as the symptoms of a large number of asthmatics are not properly controlled with the existing treatment guidelines involving corticosteroids, β2-adrenoreceptor agonists, and anti-leukotrienes or leukotriene modifiers. Promising findings have been obtained from studies exploring new treatments targeting specific immune cell mediators, which were identified as candidates in genetic studies, and cell adhesion molecules. In addition to targeting members of the Th1/Th2 inflammatory profile, mediators of the omega-3 fatty acid pathway are also emerging as novel targets of drug intervention for allergic asthma.Keywords: Allergic asthma, asthma genetics, treatments, mouse models, airway hyperresponsiveness, IgE.
Current Pharmaceutical Design
Title:Allergic Asthma: A Summary from Genetic Basis, Mouse Studies, to Diagnosis and Treatment
Volume: 22 Issue: 41
Author(s): Cynthia Kanagaratham and Danuta Radzioch
Affiliation:
Keywords: Allergic asthma, asthma genetics, treatments, mouse models, airway hyperresponsiveness, IgE.
Abstract: Asthma is an allergic disease that affects approximately 300 million people worldwide. Two of its phenotypes routinely assessed at the clinic include airway hyperresponsiveness and IgE production. They can be measured in a non-invasive manner and have been used for genetic studies.
The genetic complexity of asthma and its phenotypes makes it difficult to map their genetic contributors. Human studies require large sample sizes and proper segregation of the population to control for potential confounding factors. As an alternative, asthma genetics can be studied in mice due to the high degree of homology in the genome and immune response between mice and humans. The variety of mouse strains and allergic asthma protocols allow to study different aspects of the disease while controlling for the genetic background. Studying the genetic basis of asthma phenotypes has helped gain a better understanding of the disease mechanism. Candidate genes identified from genetic studies have served as targets for the development of new and specialized treatments. New treatments are high in demand as the symptoms of a large number of asthmatics are not properly controlled with the existing treatment guidelines involving corticosteroids, β2-adrenoreceptor agonists, and anti-leukotrienes or leukotriene modifiers. Promising findings have been obtained from studies exploring new treatments targeting specific immune cell mediators, which were identified as candidates in genetic studies, and cell adhesion molecules. In addition to targeting members of the Th1/Th2 inflammatory profile, mediators of the omega-3 fatty acid pathway are also emerging as novel targets of drug intervention for allergic asthma.Export Options
About this article
Cite this article as:
Kanagaratham Cynthia and Radzioch Danuta, Allergic Asthma: A Summary from Genetic Basis, Mouse Studies, to Diagnosis and Treatment, Current Pharmaceutical Design 2016; 22 (41) . https://dx.doi.org/10.2174/1381612822666160829141708
DOI https://dx.doi.org/10.2174/1381612822666160829141708 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Food-derived bioactive peptides against chronic diseases
Chronic diseases, such as cardiovascular diseases and metabolic diseases, have become a great threat to the human health in recent decades due to the excessive food consumption and the prevalence of sedentary lifestyle. As a class of natural compounds, food-derived bioactive peptides have been demonstrated to possess great potential for ...read more
Innovative delivery systems and formulations for the management of diseases affecting the skin and skin appendages
Skin and skin appendage diseases have high incidence and can highly impact the quality of life. Such diseases include pigmentation disorders, such as melasma, vitiligo and post-inflammatory hyperpigmentation, infectious diseases caused by fungi, viruses, bacteria and parasites, inflammatory diseases such as acne, dermatitis, rosacea, and psoriasis, as well as skin ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Novel Oral Glutarimide Derivative XC8 Suppresses Sephadex-Induced Lung Inflammation in Rats and Ovalbumin-induced Acute and Chronic Asthma in Guinea Pigs
Current Pharmaceutical Biotechnology Allergy in Pediatric Age: An Update
Current Pediatric Reviews Interaction of Synthetic Pyrethroid Insecticide Deltamethrin with Human Alpha-2-Macroglobulin: Spectroscopic and Molecular Docking Studies
Protein & Peptide Letters Association Study of IL-4 -590 C/T and DDX39B -22 G/C Polymorphisms with the Risk of Late-Onset Alzheimer’s Disease in Iranian Population
Current Aging Science Various Non-Injectable Delivery Systems for the Treatment of Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly
Current Medicinal Chemistry The Chemistry and Bio-Medicinal Significance of Pyrimidines & Condensed Pyrimidines
Current Topics in Medicinal Chemistry Leptin and Inflammation
Current Immunology Reviews (Discontinued) Phytochemical and Pharmacological Potential of <i>Ferula asafetida</i> “Hing”
Current Bioactive Compounds Silent Airflow Obstruction and Air Trapping on Discharge in Children Hospitalized with Asthma
Current Respiratory Medicine Reviews Hydrogel-clay Nanocomposites as Carriers for Controlled Release
Current Medicinal Chemistry Design and Modifications of Allergens for Improving Specific Immunotherapy
Inflammation & Allergy - Drug Targets (Discontinued) Advances in Drug Safety
Current Pharmaceutical Design siRNA as a Potential Therapy for COVID-19
Current Drug Delivery Identification of Phosphoinositide-3 Kinases Delta and Gamma Dual Inhibitors Based on the p110δ/γ Crystal Structure
Letters in Drug Design & Discovery <i>Spinacia Oleracea</i>: Exploring the Therapeutic Potential in Persian Medicine and Modern Pharmacology
Current Drug Discovery Technologies Choline Alphoscerate (Alpha-Glyceryl-Phosphoryl-Choline) An Old Choline- containing Phospholipid with a Still Interesting Profile As Cognition Enhancing Agent
Current Alzheimer Research Receptor Guided 3D-QSAR Analysis of Thieno[2,3-b]Pyridine-5- Carbonitrile Inhibitors of Protein Kinase C Theta (PKC-θ )
Combinatorial Chemistry & High Throughput Screening Subject Index To Volume 13
Current Medicinal Chemistry Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
Current Medicinal Chemistry